Spherics Inc., a
Joseph F. Finn, Jr., C.P.A. (“Finn”), Assignee of the assets of Spherics, Inc. (“Spherics”) for the benefit of creditors, announced today that all pharmaceutical intellectual property will be sold at a sealed bid auction on October 10, 2008.
One of the pieces of intellectual property for sale is its lead product, SRx-502, Topiramate Extended Release, a once-a-day version of a branded drug that currently has more than $2 billion in
Persons interested in bidding must sign a Confidentiality Agreement (“CA”) obtained from Finn's office — email@example.com or 781-237-8840. They will then receive a bid package and access to the Spherics electronic data room.
Spherics has built a strong intellectual property position around its drug delivery technologies and products. The Company has a broad range of issued US and international patents through exclusive licenses from
About Joseph F. Finn, Jr., C.P.A.
Joseph F. Finn, Jr., is the founding partner of the firm, Finn, Warnke & Gayton, Certified Public Accountants of Wellesley Hills, Massachusetts. He works primarily in the area of management consulting for distressed enterprises, bankruptcy accounting and related matters, such as assignee for the benefit of creditors and liquidating agent for a corporation. He has been involved in a number of loan workouts and bankruptcy cases for thirty-four (34) years. His most recent Assignment for the Benefit of Creditors in the Biotech field was ActivBiotics, Inc.